Task Force on Responsible Use of Natural Psychedelic Substances - Extension and Membership
HB0427 extends the existing Maryland Task Force on Responsible Use of Natural Psychedelic Substances and revises its membership. The bill keeps the task force in place for additional time, updates its reporting deadline, and requires an updated report of findings and recommendations to the Governor and General Assembly. It also adds a representative from a historically Black college or university in the State to the task force, alongside the existing mix of legislative, executive, academic, medical, behavioral health, law enforcement, patient, and policy experts.
The task force is charged with studying current laws, policies, science, risks, and barriers related to natural psychedelic substances such as psilocybin, psilocin, DMT, and mescaline, while excluding peyote. It must make recommendations for a Maryland Natural Psychedelic Substance Access Program that would support broad, equitable, and affordable access, including permitting, education and safety requirements, regulated treatment/support, and production. It must also recommend ways to move away from criminalization, including civil penalties for nonviolent conduct, expungement of records, and release of people incarcerated for nonviolent offenses involving natural psychedelic substances.
The bill amends Chapter 793 of the Acts of 2024 by extending the life of the task force and changing its membership and reporting requirements. It does not itself legalize psychedelic substances or create an access program, but it directs the task force to continue developing recommendations that could lead to major changes in Maryland law, policy, and practice regarding psychedelic access, regulation, criminal penalties, expungement, and incarceration. The bill also affects the administrative role of the Maryland Cannabis Administration, which continues to provide staff support to the task force.
The available record suggests the bill was noncontroversial enough to pass and be signed into law, with no committee transcript or recorded votes provided indicating organized opposition. The overall tone of the legislation is exploratory and policy-oriented, reflecting continued legislative interest in studying regulated access to natural psychedelic substances and in considering public health, equity, and criminal justice reforms. The addition of an HBCU representative also suggests an emphasis on broader representation and inclusion in the task force’s work.
The main substantive points of contention implied by the bill are the scope of access to psychedelic substances, the balance between public benefits and potential risks, and the extent of criminal justice reform the task force should recommend. The bill specifically directs the task force to consider civil penalties instead of criminal punishment for nonviolent conduct, expungement, and release of incarcerated individuals, which could be controversial among those concerned about drug policy changes or public safety. It also highlights barriers such as insurance, licensing, zoning, advertising, and financial services, indicating that regulated access would require coordination across multiple sectors and could face resistance from professional, regulatory, or law enforcement stakeholders.